Zhenhuan Cao

A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated‐interferon alpha

Zhenhuan Cao, Yali Liu, Lina Ma et al. · Hepatology · 2017 · 115 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China

Zhenhuan Cao, Tongzeng Li, Lianchun Liang et al. · PLoS ONE · 2020 · 68 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +10

Durability of Interferon-induced Hepatitis B Surface Antigen Seroclearance

Yali Wu, Yali Liu, Junfeng Lu et al. · Clinical Gastroenterology and Hepatology · 2019 · 64 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Potent hepatitis B surface antigen response to treatment of hepatitis‐B‐e‐antigen‐positive chronic hepatitis B with α‐interferon plus a nucleos(t)ide analog

Xinyue Chen, Zhenhuan Cao, Yali Liu et al. · Journal of Gastroenterology and Hepatology · 2011 · 16 citations

Pharmacy, Immunology, Pharmacotherapy +17

MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population

Xiaoyi Xu, Hangfei Xu, Xiaohui Liu et al. · Frontiers in Endocrinology · 2023 · 15 citations · Full text

Medicine, Genetics, Geriatric Medicine +17